Ultrasensitive label-free detection for lung cancer CYFRA 21-1 DNA based on ring-opening polymerization.

Xiaofei Li, Yawen Zhang, Lulu Hao, Yanju Liu, Xia Wang, Huaixia Yang, Jinming Kong
Author Information
  1. Xiaofei Li: Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.
  2. Yawen Zhang: Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.
  3. Lulu Hao: Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.
  4. Yanju Liu: Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.
  5. Xia Wang: Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China. Electronic address: wangxiawx83@126.com.
  6. Huaixia Yang: Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China. Electronic address: yhx998@hactcm.edu.cn.
  7. Jinming Kong: School of Environmental and Biological Engineering, Nanjing University of Science and Technology, Nanjing, 210094, PR China. Electronic address: j.kong@njust.edu.cn.

Abstract

Cytokeratin fragment antigen 21-1 (CYFRA 21-1) DNA is perceived as sensitive tumor marker for the diagnosis of non-small cell lung cancer and other tumor. Herein, linear chain poly(ε-caprolactone) (PCL) synthesized by ring-opening polymerization is applied to ultrasensitive label-free electrochemical impedance detection system for CYFRA 21-1 DNA. First, thiolated peptide nucleic acid (PNA) is self-assembled into the Au electrode surface through the formation of Au-S bonds, allowing the PNA to act as biomolecular probe and form PNA/DNA heteroduplex with the target DNA via specific hybridization. Then, PCL is conjugated to the immobilized DNA on the electrode via "carboxylate-Zr-phosphate" bridges. Finally, the electrochemical response of modified PNA/DNA/Zr/PCL electrode is determined by electrochemical impedance method to quantify of CYFRA 21-1 DNA. Under optimal conditions, this method exhibits highly sensitivity with a broad linear range (0.1 fM - 1 nM) (R = 0.995) and the limit of detection (LOD) is as low as 10.73 aM, which is equivalent to just 64 molecules in a 10 μL sample. What's more, the high selectivity, good anti-interference, label-free operation, and real-time monitoring in complex samples of the proposed strategy demonstrate its broad application for the early diagnosis and clinical monitoring.

Keywords

MeSH Term

Antigens, Neoplasm
Biosensing Techniques
Carcinoma, Non-Small-Cell Lung
DNA
Electrochemical Techniques
Humans
Keratin-19
Lung Neoplasms
Nucleic Acid Hybridization
Polymerization

Chemicals

Antigens, Neoplasm
Keratin-19
antigen CYFRA21.1
DNA

Word Cloud

Created with Highcharts 10.0.0DNA21-1CYFRApolymerizationlabel-freeelectrochemicalimpedancedetectionelectrodetumordiagnosislungcancerlinearε-caprolactonePCLring-openingnucleicacidPNAviamethodbroadmonitoringCytokeratinfragmentantigenperceivedsensitivemarkernon-smallcellHereinchainpolysynthesizedappliedultrasensitivesystemFirstthiolatedpeptideself-assembledAusurfaceformationAu-SbondsallowingactbiomolecularprobeformPNA/DNAheteroduplextargetspecifichybridizationconjugatedimmobilized"carboxylate-Zr-phosphate"bridgesFinallyresponsemodifiedPNA/DNA/Zr/PCLdeterminedquantifyoptimalconditionsexhibitshighlysensitivityrange01 fM-1 nM R = 0995limitLODlow1073aMequivalentjust64molecules10 μLsamplehighselectivitygoodanti-interferenceoperationreal-timecomplexsamplesproposedstrategydemonstrateapplicationearlyclinicalUltrasensitivebasedElectrochemicalspectroscopyPeptidePolyRing-opening

Similar Articles

Cited By